CCC Diagnostics (United States)

Recent papers from CCC Diagnostics (United States)

1. Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity studyClinical Cancer Research · 2026
2. Detection of Galactofuranose-Containing Antigens Associated With Aspergillus Extracellular Vesicles in Urine: The Biological Basis of a New Diagnostic for AspergillosisThe Journal of Infectious Diseases · 2026
3. Detection and characterization of hepatocellular carcinoma using cfDNA fragmentomesCell Press Blue · 2026
4. Coordinated Temporal Dynamics of Glucocorticoid Receptor Binding and Chromatin Landscape Drive Transcriptional Regulation2026
5. Expansion of stemlike HIV-specific CD8 ⁺ T cells and limited viral epitope diversity characterize durable posttreatment control of HIVScience Translational Medicine · 2026
6. Abstract 110: Clinical utility of landmark ctDNA molecular response as an early indicator of immunotherapy outcomes in lung cancer.Cancer Research · 2026
7. Abstract 4074: Non-invasive early detection of cancer-predisposing liver diseases using genome-wide cfDNA fragmentomesCancer Research · 2026
8. Abstract 1125: Characterizing the cfDNA fragmentome in patients with hepatocellular carcinomaCancer Research · 2026
9. Abstract 1134: Cell-free DNA fragmentomes capture response to immuno-radiotherapy in metastatic non-small cell lung cancerCancer Research · 2026
10. Abstract 5359: Precision oncology in practice: Comprehensive genomic profiling identifies actionable alterations and guides therapeutic selection in 756 clinical solid tumors.Cancer Research · 2026
11. Abstract 5325: Cell-free DNA fragmentomes for treatment response monitoring in patients with metastatic colorectal cancer: The Dolphin study.Cancer Research · 2026
12. Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIVThe Journal of Infectious Diseases · 2026
13. Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseasesScience Translational Medicine · 2026
14. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection—ReplyCancer Discovery · 2026
15. Lexicon for Clonal Hematopoiesis in Liquid BiopsyClinical and Translational Science · 2025
16. Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancerScience Advances · 2025
17. Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer DetectionClinical Cancer Research · 2025
18. Patina of precision: risk models for lung cancer screening eligibilityBMJ Oncology · 2025
19. Transcription factors form a ternary complex with NIPBL/MAU2 to localize cohesin at enhancers2024
20. Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policyJNCI Cancer Spectrum · 2024